Breadcrumb

  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Arizona Health Center COVID-19 Survey Summary Report

Arizona Health Center COVID-19 Survey Summary Report

Latest data from May 6, 2022

Number of Health Center respondents = 16 (70% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 2,414
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 79.65%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 106
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 77.46%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 16.65% 15.09%
White, Hispanic/Latino Patients 37.08% 31.13%
Black/African American, Non-Hispanic/Latino Patients 3.36% 2.83%
Black/African American, Hispanic/Latino Patients 0.29% 0.00%
Asian Patients3 0.79% 0.94%
American Indian/Alaska Native Patients3 3.85% 0.94%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00%
Patients with More Than One Race3 8.29% 7.55%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 11.52% 8.49%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.73% 0.94%
Unreported/Refused to Report Race and Ethnicity 14.46% 32.08%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 703
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 87.56%
COVID-19 Immunization Series Completed 608
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 84.69%
COVID-19 Immunization Series Additional 1,567
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 63.29%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 11.10% 13.32% 34.27%
White, Hispanic/Latino Patients 52.77% 47.86% 34.78%
Black/African American, Non-Hispanic/Latino Patients 6.69% 6.91% 2.36%
Black/African American, Hispanic/Latino Patients 0.57% 1.15% 0.13%
Asian Patients3 1.00% 0.82% 1.21%
American Indian/Alaska Native Patients3 1.99% 1.97% 1.60%
Native Hawaiian/Other Pacific Islander Patients3 0.43% 0.66% 0.19%
Patients with More Than One Race3 0.71% 0.49% 13.53%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 13.94% 13.82% 5.30%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.13% 2.14% 1.40%
Unreported/Refused to Report Race and Ethnicity 8.68% 10.86% 5.23%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 6.25%
1 to 24 Hours 31.25%
More Than 24 Hours 62.50%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 12.50%
Staffing to administer the vaccine 43.75%
Vaccine confidence 31.25%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 6.25%
None 31.25%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 12.50%
Average Percent of Health Center Visits Conducted Virtually 17.19%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 25.00%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 6
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 25.00%
None 75.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 18.75%
Patient awareness/education 6.25%
Staffing capacity 37.50%
Therapy administration/onsite logistics 25.00%
Other 6.25%
None 25.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 10
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 2,552

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 80.00%
Provided to General Public Who Came to the Health Center 50.00%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 30.00%
Provided at Other Community Events 40.00%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 10.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 20.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 10.00%
Provided to school-age children and/or their families directly or through partnerships with schools 0.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 10.00%
Other 10.00%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 6
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 5,040

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 83.33%
Provided to General Public Who Came to the Health Center 83.33%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 50.00%
Provided at Other Community Events 66.67%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 16.67%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 16.67%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 16.67%
Provided to school-age children and/or their families directly or through partnerships with schools 0.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 16.67%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 3
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 64.52%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 12.90%
White, Hispanic/Latino Patients 45.16%
Black/African American, Non-Hispanic/Latino Patients 3.23%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 3.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 12.90%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 22.58%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 19.35%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: